Discontinued — last reported Q4 '25

Non-Current Assets

Software and Technology Licenses, Net

Biogen Software and Technology Licenses, Net increased by 3.6% to $777.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 39.1%, from $559.10M to $777.50M. Over 5 years (FY 2020 to FY 2025), Software and Technology Licenses, Net shows a downward trend with a -23.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryEfficiency
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

An increase suggests ongoing investment in technology and digital capabilities, which can drive long-term operational efficiency.

Detailed definition

This represents the capitalized cost of acquired software and technology licenses, net of accumulated amortization. It r...

Peer comparison

Increasingly important across the restaurant sector as companies invest in mobile apps, kiosks, and data analytics.

Metric ID: software_technology_licenses_net

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$2.53B$2.02B$1.94B$1.77B$1.50B$1.61B$1.53B$1.38B$1.10B$754.60M$745.00M$697.60M$681.50M$631.40M$560.50M$559.10M$637.70M$729.70M$750.60M$777.50M
QoQ Change-20.2%-3.9%-8.9%-15.1%+7.4%-5.2%-9.7%-20.0%-31.7%-1.3%-6.4%-2.3%-7.4%-11.2%-0.2%+14.1%+14.4%+2.9%+3.6%
YoY Change-40.6%-20.1%-21.2%-21.9%-26.4%-53.2%-51.3%-49.5%-38.3%-16.3%-24.8%-19.9%-6.4%+15.6%+33.9%+39.1%
Range$559.10M$2.53B
CAGR-22.0%
Avg YoY Growth-18.8%
Median YoY Growth-21.5%
Current Streak4 quarters growth

Frequently Asked Questions

What is Biogen's software and technology licenses, net?
Biogen (BIIB) reported software and technology licenses, net of $777.50M in Q1 2026.
How has Biogen's software and technology licenses, net changed year-over-year?
Biogen's software and technology licenses, net increased by 39.1% year-over-year, from $559.10M to $777.50M.
What is the long-term trend for Biogen's software and technology licenses, net?
Over 5 years (2020 to 2025), Biogen's software and technology licenses, net has grown at a -23.7% compound annual growth rate (CAGR), from $2.90B to $750.60M.
What does software and technology licenses, net mean?
The net book value of the company's software and technology licenses.